Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system

Larochelle, Catherine, Cayrol, Romain, Kebir, Hania, Alvarez, Jorge Ivan, Lécuyer, Marc-André, Ifergan, Igal, Viel, Émilie, Bourbonnière, Lyne +11 more·2012·Brain
DOI 10.1093/brain/aws212

Cited by (145)

Items 101–145 of 145

  1. Pro‐Inflammatory c ‐Met + CD4 T Cells in Multiple Sclerosis
    Gautier Bréville, Mahdia Benkhoucha, Ayman Rezk, Ngoc Lan Tran, Isis Senoner, Amit Bar‐Or, Patrice H. Lalive · 2025 · Annals of Neurology
  2. The multifaceted roles of MCAM in development, homeostasis, pathological conditions, and cancer
    Bartosz Mierzejewski, Dominika Kulma, Edyta Brzóska · 2025 · Journal of Molecular Medicine
  3. Nutritional Modulation of Impaired Blood-Brain Barrier Integrity and Function in Major Depression
    Miroslav Adžić, Iva Lukić, Miloš Mitić, Ester Francija Zerajic, Emilija Glavonic, Milan Jovanović, Sanja Ivković · 2025 · International Journal of Molecular Sciences
  4. Melanoma Cell Adhesion Molecule Expressing Helper T Cells in CNS Inflammatory Demyelinating Diseases
    Ryotaro Ikeguchi, Yuko Shimizu, Akihiro Kondo, Natsuki Kanda, Hayato So, Haruka Kojima, Kazuo Kitagawa · 2021 · Neurology Neuroimmunology & Neuroinflammation
  5. Blood–brain barrier: A novel therapeutic target in multiple sclerosis
    Hiroya Kuwahara, Kazutaka Nishina, Takanori Yokota · 2015 · Clinical and Experimental Neuroimmunology
  6. Cell adhesion molecule MCAM on pathogenic T cells—a green light for CNS entry in multiple sclerosis
    Katy Malpass · 2012 · Nature Reviews Neurology
  7. Chemokine receptors on T cells in multiple sclerosis
    W. Sato · 2014 · Clinical and Experimental Neuroimmunology
  8. Identification of essential modules regulating T cell migration to the central nervous system in multiple sclerosis
    Arek Kendirli, Clara de la Rosa, Katrin F. Lämmle, Klara Eglseer, Isabel Bauer, Vladyslav Kavaka, Stephan Winklmeier, Christian Werner Wichmann, Lisa-Ann Gerdes, Tania Kümpfel et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  9. CD70-induced differentiation of proinflammatory Th1/17/22/GM lymphocytes associated with disease progression and immune reconstitution during HIV infection
    Xinyue Wang, Yuqing Wei, Zhijiao He, Di Wang, Leidan Zhang, Juan Du, Mengyuan Zhang, Meiqing Jiang, Na Chen, Meiju Deng et al. · 2023 · Emerging Microbes & Infections
  10. CD146, a therapeutic target involved in cell plasticity
    Zhenzhen Wu, Yuzhe Zang, Chuyi Li, Zhiheng He, Jingyu Liu, Zhaoqi Du, Xinran Ma, Lin Jing, Hongxia Duan, Jing Feng et al. · 2024 · Science China Life Sciences
  11. The correlation of GluR3B antibody with T lymphocyte subsets and inflammatory factors and their role in the progression of epilepsy
    Qingwei Lai, Nuan Wang, Binbin Wang, Yue Chen · 2024 · Journal of Translational Medicine
  12. Molecular targeted therapy against the blood–brain barrier in multiple sclerosis
    Takashi Kanda · 2014 · Clinical and Experimental Neuroimmunology
  13. Pathways Across the Blood-Brain Barrier
    Michael Abadier, Ruth Lyck · 2017 · Springer eBooks
  14. Neuroglia and the blood–brain barrier
    Henrique Nogueira Pinto, Parand Zarekiani, Helga E. de Vries · 2025 · Handbook of clinical neurology
  15. Investigating anti-inflammatory and immunomodulatory properties of brivaracetam and lacosamide in experimental autoimmune encephalomyelitis (EAE)
    Oumarou Ouédraogo, Renaud Balthazard, Victoria Hannah Mamane, Hélène Jamann, Florence Millette, Audrey Daigneault, Nathalie Arbour, Catherine Larochelle · 2023 · Epilepsy Research
  16. Blood-Brain Barrier Disruption in Multiple Sclerosis
    Ruben van Doorn · 2015 · CRC Press eBooks
  17. Immunocytochemical Assessment of Blood–Brain Barrier Structure, Function, and Damage
    Jean‐Pierre Louboutin · 2015 · Neuromethods
  18. Review and prospect of CD146 research
    Jingyu Liu, XinRan MA, Qingji Xu, Xiyun Yan, Chaoliang Xiong, Jing Feng, Daji Wang, Hongxia Duan, Jianquan Xiang, Zhiheng He et al. · 2020 · Scientia Sinica Vitae
  19. EGFL7 – a potential therapeutic target for multiple sclerosis?
    Timo Uphaus, Frauke Zipp, Catherine Larochelle · 2018 · Expert Opinion on Therapeutic Targets
  20. Targeting MCAM for next-generation modulation of leucocyte trafficking
    Tilman Schneider‐Hohendorf, Heinz Wiendl · 2023 · Brain
  21. Interleukin‐33/suppression of tumorigenicity 2 system: Can it be a future therapeutic target for neuroimmunological disorders?
    Takashi Kanda · 2013 · Clinical and Experimental Neuroimmunology
  22. Proteomes and Biomarkers of the Neurovascular Unit
    Arsalan S. Haqqani, Danica B Stanimirovic · 2017 · Primer on Cerebrovascular Diseases
  23. Simplified assay for enrichment of primed human Th17 and Tc17 lymphocytes from peripheral blood
    Pradeep Kumar Dagur, Elena Stansky, Ankit Saxena, Angélique Biancotto, John Philip McCoy · 2019 · Translational Medicine Communications
  24. Immune Response in the Human Central Nervous System in Multiple Sclerosis and Stroke
    Hans Lassmann · 2015 · Wiley eBooks
  25. Blood-brain barrier integrity and prevalence of intrathecal T helper 17.1 cells in Huntington´s disease
    Birna Ásbjörnsdóttir, Christian Sandøe Musaeus, Marie N.N. Hellem, Tua Vinther‐Jensen, Patrick Ejlerskov, Esben Budtz–Jørgensen, Filippa Liliendahl Qvist, Anja Hviid Simonsen, Lena E. Hjermind, Niels Henning Skotte et al. · 2026 · PLoS ONE
  26. In Vitro CNS Models
    Aslı Kara, Naile Öztürk, İmran Vural · 2017 · Elsevier eBooks
  27. Blood-Brain Barrier Disruption in Multiple Sclerosis
    Mark Ronald Mizee, Ruben van Doorn, Alexandre Prat, Helga E. de Vries · 2015 · CRC Press eBooks
  28. In Vitro Models of CNS Barriers
    N. Joan Abbott, Siti Rafidah Yusof, Andreas Reichel, Diana E. M. Dolman, Jane Elizabeth Preston · 2022 · AAPS advances in the pharmaceutical sciences series
  29. Roles of CD4 and CD8 T Lymphocytes in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
    Nathalie Arbour, Alexandre Prat · 2015 · Wiley eBooks
  30. In Vivo Imaging of Glial and Immune Cell Responses in Central Nervous System Injury and Disease
    Alexandre Paré, S. Lacroix · 2015
  31. Accumulating knowledge of the barrier system in the central and peripheral nervous system: What's next?
    Takashi Kanda · 2015 · Clinical and Experimental Neuroimmunology
  32. Inflammation at the Blood–Brain Barrier in Multiple Sclerosis
    Mark Ronald Mizee, Ruben van Doorn, Alexandre Prat, Helga E. de Vries · 2013 · Topics in medicinal chemistry
  33. The stimulatory role of ICOS in the development of CD146+CCR5+ T cells co-expressing IFN-γ and IL-17 during graft-versus-host disease
    Liangyi Liu · 2015 · IUScholarWorks (Indiana University)
  34. Leukocyte Entry into the Brain
    Katerina Dorovini‐Zis, Donald K. Wong, Kenneth Liu · 2015
  35. 後腹膜に発生した悪性血管周皮腫の1例(骨・軟部-(3), 第44回日本臨床細胞学会秋期大会)
    幸久 藤田, 和子 田中, 和彦 若林, 孝詞 宮元, 恵美 岩井, 隆善 神田, 伸一 中塚 · 2005 · 日本臨床細胞学会雑誌
  36. Leukocyte Entry into the Brain
    Katerina Dorovini‐Zis, Donald K. Wong, Kenneth Liu · 2015 · CRC Press eBooks
  37. Cytotoxic T lymphocytes in multiple sclerosis: New targets for treatment?
    Vinicius de Oliveira Boldrini · 2023 · Elsevier eBooks
  38. การแสดงออกของซด�146�ในรอยโรคไลเคน�แพลนสและมะเรงชองปากในผปวยไทย�
    สรินธร ปริยะวาที, กอบกาญจน์ ทองประสม, เอกรัฐ ภัทรธราธิป · 2017
  39. The blood-brain barrier in multiple sclerosis
    Bettina Zierfuss, Marc Charabati, Brian A. MacVicar, Stéphanie Zandee, Alexandre Prat · 2024 · Elsevier eBooks
  40. Unveiling the Mysteries of the Blood-brain Barrier: The Problem of the Brain/spinal Pharmacotherapy
    Aditya Walia, Amandeep Kaur, Randhir Singh, Nidhi Rani, Rajan Swami · 2024 · Central Nervous System Agents in Medicinal Chemistry
  41. Prioritization of Therapeutic Targets of Inflammation Using Proteomics, Bioinformatics, and In Silico Cell–Cell Interactomics
    Arsalan S. Haqqani, Danica B Stanimirovic · 2025 · Methods in molecular biology
  42. Rôle de CD146 dans l'athérosclérose
    Muriel G. Blin · 2016
  43. Adaptive immune dysregulation drives new-onset refractory status epilepticus
    Zhi-Ying Phong, Si‐Lei Fong, Kheng-Seang Lim, Suhailah Abdullah, Hong-Gee Lee, Ching Soong Khoo, Chung Yeng Looi, Won Fen Wong · 2026 · Frontiers in Immunology
  44. Mid-life candidate vascular plasma biomarkers are associated with MRI markers of vascular brain injury and amyloid- and tau-PET in cognitively healthy adults
    Martin D. Mulligan, Ruiqi Wang, Qiong Yang, Alexa Beiser, Pauline Maillard, Claudia Liliana Satizábal, Saptaparni Ghosh, Jeremy A. Tanner, Keith A. Johnson, Charles S DeCarli et al. · 2026 · Journal of Alzheimer s Disease
  45. Blood–Brain Barrier and Its Overlooked Proteoglycan Regulators
    Rhiannon Champagne, Jordan Myers, Hannah Pearson, Kaylie Wenke, Danny Varghese, Anurag Purushothaman · 2026 · Biomolecules